Michael Matson
Stock Analyst at Needham
(2.66)
# 2,037
Out of 4,876 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $119.47 | +254.06% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $7.08 | +1,171.19% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $93.50 | -43.32% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $58.60 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $255.16 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $106.53 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $45.75 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $393.55 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $18.34 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $65.01 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.51 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.32 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $47.15 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $119.47
Upside: +254.06%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $7.08
Upside: +1,171.19%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $93.50
Upside: -43.32%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $58.60
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $255.16
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $106.53
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $45.75
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $393.55
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $18.34
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $65.01
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $67.51
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.32
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $47.15
Upside: -